MRNA: Moderna, Inc. Stock Live Price Graph
Moderna, Inc. stock live price (US Dollar), charts and analysis. Get MRNA stock market news.
Moderna, Inc. (MRNA)
Loading chart...
About the company
Moderna, Inc., a biotechnology firm, is dedicated to the discovery, development, and commercialization of messenger RNA (mRNA) based therapies and preventive medicines. Its extensive research and development efforts target a broad spectrum of medical needs, including infectious diseases, cancer immunology, rare conditions, cardiovascular ailments, and autoimmune disorders, with operations spanning the United States, Europe, and other global markets. The company's diverse product pipeline encompasses various vaccine candidates: those for respiratory illnesses like COVID-19, influenza, and respiratory syncytial virus (RSV); latent viral infections such as cytomegalovirus (CMV), Epstein-Barr virus (EBV), human immunodeficiency virus (HIV), herpes simplex virus (HSV), and varicella-zoster virus (VZV); and public health threats like Zika and Nipah. Additionally, Moderna is advancing systemic secreted and cell surface-targeted therapeutics, an array of cancer vaccines (including personalized, KRAS, and checkpoint varieties), intratumoral immuno-oncology products, localized regenerative treatments, systemic intracellular medicines, and inhaled pulmonary solutions. Moderna maintains strategic alliances with several prominent entities, including AstraZeneca PLC, Merck & Co., Inc., Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited, Carisma Therapeutics, Inc., Metagenomi, Inc., the Defense Advanced Research Projects Agency (DARPA), the Biomedical Advanced Research and Development Authority (BARDA), the Institute for Life Changing Medicines, and The Bill & Melinda Gates Foundation. It also holds a collaboration and license agreement with Chiesi Farmaceutici S.P.A. Founded in 2010 as Moderna Therapeutics, Inc., the company officially became Moderna, Inc. in August 2018. Its corporate headquarters are located in Cambridge, Massachusetts.
Company profile
Market News & Analysis
Dividend History
No dividend or corporate action data is available for this instrument.
What Is MRNA? Live MRNA Prices and Analysis
MRNA, or Moderna, Inc., is a biotechnology company primarily focused on drug discovery and development based on messenger RNA (mRNA) technology. Founded in 2010, Moderna gained international prominence for its COVID-19 vaccine, which was one of the first vaccines authorized for emergency use during the pandemic. Investors closely monitor MRNA due to its innovative approach to vaccine development and the potential of its mRNA platform in treating a variety of diseases.
As a publicly traded company on the Nasdaq under the ticker symbol MRNA, its performance is crucial not only for individual investors but also for the broader healthcare and biotechnology sectors. The stock is often viewed as a bellwether for advancements in mRNA technology and its applications in medicine.
Frequently asked questions
What is the MRNA stock price?
The latest MRNA (Moderna, Inc. (MRNA)) stock price is 196.4800 USD. Follow the live quote and chart on this page for real-time updates.
What are MRNA's intraday ceiling and floor prices?
For MRNA, the intraday ceiling is 197.5500 USD and the floor is 182.5120 USD. These levels may update during the session.
What is MRNA's previous closing price?
The previous closing price for MRNA is 187.4600 USD.
What is MRNA's trading volume?
The current trading volume for MRNA is 14,597,511. Volume can change throughout the session.
Where can I see the live MRNA price?
You can follow the live MRNA (Moderna, Inc. (MRNA)) price in the quote area and chart at the top of this Investvio overview page.
Where can I see MRNA historical prices and charts?
The current price chart for MRNA (Moderna, Inc. (MRNA)) is on this overview page. For longer historical prices and archive data, open the Archive tab and choose a period to review past performance.